Drug intelligence / Profile preview

atorvastatin + aspirin

Development stage
Unknown
Lead developer
Learmont Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Atorkit ASP 75 is a fixed-dose combination generic medication containing atorvastatin and aspirin (acetylsalicylic acid). Atorvastatin is a lipid-lowering agent that acts as a competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels. Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), preventing the synthesis of thromboxane A2 and subsequent platelet aggregation. This combination is used for the secondary prevention of cardiovascular events in patients with established atherosclerotic cardiovascular disease, addressing both dyslipidemia and thrombotic risk.

Brand names
Atorkit ASP 75
Other names
atorvastatin and aspirinatorvastatin/aspirin
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on atorvastatin + aspirin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on atorvastatin + aspirin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call